High Disease Control And State Of Remission With Risankizumab In Patients With Moderate-To-Severe Psoriasis During The 6-Year Limmitless Study
AuthID
P-016-SK7
P-016-SK7
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service